Moritz Fürstenau, MD

Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne and Duesseldorf, German CLL Study Group, Faculty of Medicine and University Hospital Cologne, University of Cologne
Cologne, Germany

N/A

Presentation(s):

• YIM Session 4: Clinical Approach Considerations and Treatment Options in CLL

  Friday, September 12, 2025
  12:45 - 13:50 CEST

• (1442) NGS-based MRD assessment refines prognostication after venetoclax-based first-line combinations for chronic lymphocytic leukemia: A prospective analysis of the phase 3 GAIA/CLL13 trial

  Sunday, September 14, 2025
  09:10 - 09:20 CEST